AIDS Alert Archives – October 1, 2004
October 1, 2004
View Issues
HIV/HCV coinfection cases require special attention
Until recently, an HIV and hepatitis C (HCV) coinfected patient who was managing well with HIV antiretrovirals might die from liver disease due to HCV infection. Now treatment has advanced, and the health prospects for coinfected patients are brighter than ever.One size doesn’t fit all in Hispanic population
Organizations successfully targeting Latino populations for HIV services and prevention have developed strategies specific to very different groups, including young men who have sex with men (MSM); rural, low-income Hispanics, and Latino migrants or Mexican border town residents.Motivational interviewing seeks specific solutions
The key to a four-session HIV prevention for positives program targeting Latinos, called Positively Latino, is the adaptation of the theoretical model of motivational interviewing, which is a different approach than the traditional case management model.Program finds success reaching crack addicts
A new study reports success in reducing risk and improving womens housing and employment status after enrollment in a woman-focused HIV intervention program.Physicians counsel new patients more effectively
The Centers for Disease Control and Prevention (CDC) is focusing on the role of physicians in its prevention for positives initiative, but according to one survey funded by the agency, the available prevention counseling is less than optimal.FDA Notifications
The FDA has approved injectable poly-L-lactic acid, an injectable filler to correct facial fat loss in HIV patients.New web page launched for HIV drug deliberations
The FDA has developed a web page to consolidate records of advisory committee meetings related to HIV/AIDS and associated conditions, making them easier to access.